In this exchange, Vijay Kunadian and Javier Escaned explore the real-world implementation of INOCA (Ischemia with Non-Obstructive Coronary Arteries) and ANOCA (Angina with Non-Obstructive Coronary Arteries) diagnostic pathways. Drawing on the 2024 CCS (Chronic Coronary Syndromes) guidelines, and the EAPCI consensus document, they discuss why these...

Managing STEMI patients with multivessel disease is a complex challenge evolving rapidly thanks to new clinical evidence. Angela Mcinerney, Natalia Pinilla, and Matthias Götberg explore how findings from the COMPLETE trial and its intracoronary imaging substudy are reshaping treatment strategies.

Their discussion highlights the role of intracoronary...

Robert Byrne and Bruno Scheller explore the current role of drug-coated balloon (DCB) angioplasty nearly two decades after its initial clinical use. This discussion covers when and how to apply DCB angioplasty effectively in everyday practice, focusing on lesion preparation for de novo coronary disease and...

This interview with Michael Haude and Thomas Cuisset explores findings from the PREVENT trial, which included over 1,600 patients with vulnerable, physiologically non-significant plaques identified by IVUS.

Patients were randomised to optimal medical therapy (OMT) alone or OMT plus preventive PCI. While the composite endpoint favoured the PCI...

Howard Herrmann and Raj Makkar discuss a sub-study of the ACURATE IDE trial, which examined valve under-expansion detected by fluoroscopy. Among 1,500 patients with aortic stenosis, 22 % of ACURATE neo2 valves showed under-expansion, often linked to heavy valve calcification.

Patients with under-expanded valves faced higher risks...

Giuseppe Di Gioia and Jens Flensted Lassen explore the essentials of the provisional stenting strategy for non-left main true bifurcation lesions. This stepwise approach offers simplicity while preserving flexibility: start with one stent in the main vessel, and keep the option open for a second if...

During EuroPCR 2025, Cleverson Zukowski and Pablo Lamelas introduce a landmark initiative: the first clinical guidelines for left main disease specifically developed for Latin America.

Published by the Latin American Society of Interventional Cardiology (SOLACI) and the Interamerican Society of Cardiology (SIAC), these recommendations aim to support...

When is the right time to perform TAVI—and how should coexisting coronary artery disease be managed? In this interview, Liesbeth Rosseel, Davide Capodanno, and Michael Joner tackle these two timely questions. They share key takeaways from the EARLY-TAVI trial, which demonstrated reduced rehospitalisation with early intervention...

At EuroPCR 2025, Christopher Cook, Philippe Genereux, and Victoria Delgado discuss key results from the EARLY TAVR study.

In asymptomatic patients with severe aortic stenosis, early intervention was associated with significantly less cardiac damage at 2 years, compared to a surveillance strategy that led to extensive damage...

More effective, safer treatment is needed for functional mitral regurgitation (FMR), a consequence of myocardial disease and left ventricular disease, which is associated with poor quality of life and high mortality rates. Join Ralph Stephan von Bardeleben, Patrice Guerin and Saibal Kar as they examine the...

Do newer generation drug-eluting stents with ultrathin struts improve clinical outcomes for patients undergoing percutaneous coronary intervention (PCI)? Join Ashwin Mehta, Upendra Kaul and Anirban Choudhary in a discussion about the TALENT non-inferiority trial, which compared PCI using the Supraflex sirolimus-eluting stent with ultrathin struts with...

What is the best size of MitraClip to use for functional mitral regurgitation, degenerative mitral regurgitation or commissural lesions? Francesco Maisano (Switzerland), Paolo Denti (Italy) and Ralph Stephan von Bardeleben (Germany) examine the latest data from the EXPAND trial, which show the real-world use of percutaneous...

Are left main bifurcations different from other bifurcations? And is one stent better than two? Find out as Goran Stankovic, David Hildick-Smith and Francesco Burzotta discuss the recommendations of the latest consensus document from the European Bifurcation Club (EBC) dedicated to left main percutaneous coronary intervention...

How effective are risk scores at stratifying patients into different surgical risk groups before transcatheter aortic valve implantation (TAVI)? How do the rates of mortality, stroke and paravalvular leak after TAVI using the Portico TAVI System compare between patients assigned different risk scores? Join Lars Søndergaard...

A session at EuroPCR 2019 was dedicated to the truths and myths surrounding renal denervation. Does ablation location matter? Is safe and successful denervation as simple as measuring ablation depth? Should renal denervation be avoided in patients with isolated hypertension? Is the effect of renal denervation...

Join Hélène Eltchaninoff and Hendrik Treede as they talk to Bernard Prendergast about the impact of the latest evidence from the field of TAVI on everyday clinical practice. 2019 has been a landmark year for valve disease, with the results of the PARTNER 3 trial and...

Join Nicolas Dumonteil as he looks at some of the factors that can help optimise the safety and efficiency of modern transfemoral TAVI procedures. Discover what considerations need to be taken into account when choosing a TAVI device.

What is the best way to minimise the risk...

It has been a year since the most recent sham controlled trials of renal denervation (RDN) were presented at EuroPCR. Join Felix Mahfoud as he talks to Roland Schmieder and Flavio Ribichini about what they have learned since. Find out what has changed in terms of...

PCR Webinars provide you with free online post-graduate education in interventional cardiovascular medicine from the comfort of your home or office. These live webinars are interactive, offering you the chance to post online questions and comments to renowned and seasoned operators. What better way to improve...

Although huge progress has been made over the last four decades in percutaneous coronary intervention, the results in diabetic patients are still suboptimal, with higher rates of restenosis, target lesion revascularisation, vessel failures and mortality. Luca Testa, Roxana Mehran and Ashok Seth discuss the problems that...